Astrid Breitschaft
Berlin, BE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Effect of oral semaglutide on energy intake, appetite, control of eating and gastric emptying in adults living with obesity: A randomized controlled trial.
Journal: Diabetes, obesity & metabolism
Published: April 19, 2024
Correction to: Midostaurin drug interaction profile: a comprehensive assessment of CYP3A, CYP2B6, and CYP2C8 drug substrates, and oral contraceptives in healthy participants.
Journal: Cancer chemotherapy and pharmacology
Published: March 04, 2024
Effect of midostaurin on the pharmacokinetics of P-gp, BCRP, and CYP2D6 substrates: assessing potential drug-drug interactions in healthy participants : Brief title: Drug-drug interaction of midostaurin.
Journal: Cancer chemotherapy and pharmacology
Published: February 02, 2024
Midostaurin drug interaction profile: a comprehensive assessment of CYP3A, CYP2B6, and CYP2C8 drug substrates, and oral contraceptives in healthy participants.
Journal: Cancer chemotherapy and pharmacology
Published: October 20, 2023
Effect of oral semaglutide on the pharmacokinetics of thyroxine after dosing of levothyroxine and the influence of co-administered tablets on the pharmacokinetics of oral semaglutide in healthy subjects: an open-label, one-sequence crossover, single-center, multiple-dose, two-part trial.
Journal: Expert opinion on drug metabolism & toxicology
Published: July 22, 2021
Effect of Oral Semaglutide on the Pharmacokinetics of Levonorgestrel and Ethinylestradiol in Healthy Postmenopausal Women and Furosemide and Rosuvastatin in Healthy Subjects.
Journal: Clinical pharmacokinetics
Published: March 30, 2021
Effect of Various Dosing Conditions on the Pharmacokinetics of Oral Semaglutide, a Human Glucagon-Like Peptide-1 Analogue in a Tablet Formulation.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: March 26, 2021
Absence of QTc Prolongation with Sodium N-(8-[2-Hydroxybenzoyl] Amino) Caprylate (SNAC), an Absorption Enhancer Co-Formulated with the GLP-1 Analogue Semaglutide for Oral Administration.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: February 19, 2021
The effect of semaglutide 2.4 mg once weekly on energy intake, appetite, control of eating, and gastric emptying in adults with obesity.
Journal: Diabetes, obesity & metabolism
Published: September 10, 2020
A randomized study investigating the effect of omeprazole on the pharmacokinetics of oral semaglutide.
Journal: Expert opinion on drug metabolism & toxicology
Published: June 14, 2018
Effects of Subcutaneous Pasireotide on Cardiac Repolarization in Healthy Volunteers: a Single‐Center, Phase I, Randomized, Four‐Way Crossover Study.
Journal: Journal of clinical pharmacology
Published: June 20, 2013
Last Updated: 09/26/2026